Polymorphisms in the IL10 but not in the IL1beta and IL4 genes are associated with inhibitor development in patients with hemophilia A

Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis.

2001 • 772 citations

Definitions in Hemophilia

2001 • 708 citations

The Nijmegen Modification of the Bethesda Assay for Factor VIII:C Inhibitors: Improved Specificity and Reliability

1995 • 640 citations

The epidemiology of inhibitors in haemophilia A: a systematic review

2003 • 603 citations

The IL-1 family and inflammatory diseases.

2004 • 597 citations

Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus.

1995 • 542 citations

A More Uniform Measurement of Factor VIII Inhibitors

1975 • 498 citations

Haemophilia A: Mutation Type Determines Risk of Inhibitor Formation

1995 • 336 citations

Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity

1995 • 281 citations

Allelic polymorphism in IL-1β and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease

1995 • 203 citations

The Malmö International Brother Study (MIBS): further support for genetic predisposition to inhibitor development

2001 • 202 citations

Association of asthma and the interleukin‐4 promoter gene in Japanese

1998 • 202 citations

Inhibitor development in correlation to factor VIII genotypes

2002 • 166 citations

Environmental and genetic factors influencing inhibitor development

2004 • 163 citations

A polymorphic dinucleotide repeat in the human IL-10 promoter

1995 • 149 citations

Inhibitors in congenital coagulation disorders

2004 • 147 citations

The Malmö International Brother Study (MIBS). Genetic defects and inhibitor development in siblings with severe hemophilia A.

2005 • 91 citations

Polymorphisms in IL-1β and IL-1 receptor antagonist genes are associated with myasthenia gravis

1998 • 84 citations

The Role of Genetics in Inhibitor Formation

1999 • 83 citations

Genetic Susceptibility Markers in Danish Patients with Type 1 (Insulin-Dependent) Diabetes-Evidence for Polygenecity in Man

1994 • 68 citations

Inhibitors in haemophilia: clinical aspects

2004 • 59 citations

The genetic basis of inhibitor development in haemophilia A

1998 • 53 citations

Markers in the promoter region of interleukin-10 (IL-10) gene in myasthenia gravis: implications of diverse effects of IL-10 in the pathogenesis of the disease

1999 • 53 citations

Interleukin-10 gene promoter polymorphisms in multiple myeloma

2001 • 49 citations

Novel genetic association of Wegener's granulomatosis with the interleukin 10 gene.

2002 • 46 citations

Promoter Polymorphism in the Candidate Genes, IL–4, IL–9, TGF–β1, for Atopy and Asthma

1999 • 45 citations

Treatment of the Bleeding Inhibitor Patient

2003 • 39 citations

Mutation Profiling in Haemophilia A

2001 • 37 citations

How do some haemophiliacs develop inhibitors?

1998 • 32 citations

Mapping of genes that control the antibody response to human factor IX in mice

2004 • 31 citations

Cited By (0)

Loading...